Literature DB >> 9258532

Microbiologic data overview of Italian cystic fibrosis patients.

G Taccetti1, S Campana.   

Abstract

The aim of our study was to determine the frequency of microbiological culturing and prevalence of colonization by principal pathogens of the respiratory tract of Italian cystic fibrosis patients. Data on all Italian cystic fibrosis patients were collected using a questionnaire sent to all Italian CF Centers. Results were obtained of microbiological cultures from 2,521 patients. Information was gained regarding the method of gathering biological samples, the percentage of patients undergoing microbiological culturing regularly, the procedures used to isolate bacteria and types of culture media used which were selective for Burkholderia cepacia. Ninety-four percent of Italian CF patients are regularly tested microbiologically. Sputum and pharyngeal cultures are most often carried out. 49% of Italian patients are colonized by Staphylococcus aureus, 5.4% by Haemophilus influenzae, 48.9% by Pseudomonas aeruginosa and 3.8% by Burkholderia cepacia. In Italy there is a high prevalence of CF patients colonized by Staphylococcus aureus and a low prevalence of patients colonized by Haemophilus influenzae. The prevalence of Burkholderia cepacia and Pseudomonas aeruginosa does not differe significantly from other countries examined.

Entities:  

Mesh:

Year:  1997        PMID: 9258532     DOI: 10.1023/a:1007373700089

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  13 in total

Review 1.  Cystic fibrosis: respiratory problems and their treatment.

Authors:  M E Hodson; J O Warner
Journal:  Br Med Bull       Date:  1992-10       Impact factor: 4.291

Review 2.  Regulation of ion channels by ABC transporters that secrete ATP.

Authors:  Q al-Awqati
Journal:  Science       Date:  1995-08-11       Impact factor: 47.728

3.  Cystic Fibrosis Foundation guidelines for patient services, evaluation, and monitoring in cystic fibrosis centers. The Cystic Fibrosis Foundation Center Committee and Guidelines Subcommittee.

Authors: 
Journal:  Am J Dis Child       Date:  1990-12

4.  CFTR as a cAMP-dependent regulator of sodium channels.

Authors:  M J Stutts; C M Canessa; J C Olsen; M Hamrick; J A Cohn; B C Rossier; R C Boucher
Journal:  Science       Date:  1995-08-11       Impact factor: 47.728

5.  CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP.

Authors:  E M Schwiebert; M E Egan; T H Hwang; S B Fulmer; S S Allen; G R Cutting; W B Guggino
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

6.  Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis.

Authors:  S Whittier; R L Hopfer; M R Knowles; P H Gilligan
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

Review 7.  Cystic fibrosis gene.

Authors:  A Harris
Journal:  Br Med Bull       Date:  1992-10       Impact factor: 4.291

8.  The changing epidemiology of cystic fibrosis.

Authors:  S C FitzSimmons
Journal:  J Pediatr       Date:  1993-01       Impact factor: 4.406

9.  Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator.

Authors:  H Zar; L Saiman; L Quittell; A Prince
Journal:  J Pediatr       Date:  1995-02       Impact factor: 4.406

10.  Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis.

Authors:  P Kubesch; T Dörk; U Wulbrand; N Kälin; T Neumann; B Wulf; H Geerlings; H Weissbrodt; H von der Hardt; B Tümmler
Journal:  Lancet       Date:  1993-01-23       Impact factor: 79.321

View more
  6 in total

1.  Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.

Authors:  S Campana; G Taccetti; N Ravenni; F Favari; L Cariani; A Sciacca; D Savoia; A Collura; E Fiscarelli; G De Intinis; M Busetti; A Cipolloni; A d'Aprile; E Provenzano; I Collebrusco; P Frontini; G Stassi; M Trancassini; D Tovagliari; A Lavitola; C J Doherty; T Coenye; J R W Govan; P Vandamme
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Molecular typing and exopolysaccharide biosynthesis of Burkholderia cepacia isolates from a Portuguese cystic fibrosis center.

Authors:  J A Richau; J H Leitão; M Correia; L Lito; M J Salgado; C Barreto; P Cescutti; I Sá-Correia
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

3.  Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status.

Authors:  A Agodi; E Mahenthiralingam; M Barchitta; V Gianninò; A Sciacca; S Stefani
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

4.  Multiresistant non-fermentative gram-negative bacteria in cystic fibrosis patients: the results of an Italian multicenter study. Italian Group for Cystic Fibrosis microbiology.

Authors:  G Taccetti; S Campana; L Marianelli
Journal:  Eur J Epidemiol       Date:  1999-01       Impact factor: 8.082

5.  Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Authors:  R M Shawar; D L MacLeod; R L Garber; J L Burns; J R Stapp; C R Clausen; S K Tanaka
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

6.  Allergic bronchopulmonary aspergillosis in Italian cystic fibrosis patients: prevalence and percentage of positive tests in the employed diagnostic criteria.

Authors:  G Taccetti; E Procopio; L Marianelli; S Campana
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.